These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1665786)

  • 1. Memory enhancing effects of granisetron (BRL 43694) in a passive avoidance task.
    Chugh Y; Saha N; Sankaranarayanan A; Sharma PL
    Eur J Pharmacol; 1991 Oct; 203(1):121-3. PubMed ID: 1665786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.
    Upward JW; Arnold BD; Link C; Pierce DM; Allen A; Tasker TC
    Eur J Cancer; 1990; 26 Suppl 1():S12-5. PubMed ID: 2169778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of nitric oxide in granisetron improving effect on scopolamine-induced memory impairment in mice.
    Javadi-Paydar M; Zakeri M; Norouzi A; Rastegar H; Mirazi N; Dehpour AR
    Brain Res; 2012 Jan; 1429():61-71. PubMed ID: 21875703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ethological study of the effects of buspirone and the 5-HT3 receptor antagonist, BRL 43694 (granisetron) on behaviour during social interactions in female and male mice.
    Cutler MG
    Neuropharmacology; 1991 Apr; 30(4):299-306. PubMed ID: 1649417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enhancement of retention induced by vasopressin in mice may be mediated by an activation of central nicotinic cholinergic mechanisms.
    Faiman CP; de Erausquin GA; Baratti CM
    Behav Neural Biol; 1991 Sep; 56(2):183-99. PubMed ID: 1759940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).
    Sanger GJ; Nelson DR
    Eur J Pharmacol; 1989 Jan; 159(2):113-24. PubMed ID: 2540014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of granisetron and lorazepam, alone and in combination, on the EEG of human volunteers.
    Link CG; Leigh TJ; Fell GL
    Br J Clin Pharmacol; 1991 Jan; 31(1):93-7. PubMed ID: 1849732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose effects on memory: behavioral and pharmacological characteristics.
    Gold PE; Vogt J; Hall JL
    Behav Neural Biol; 1986 Sep; 46(2):145-55. PubMed ID: 3767828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats.
    Foley AG; Murphy KJ; Hirst WD; Gallagher HC; Hagan JJ; Upton N; Walsh FS; Regan CM
    Neuropsychopharmacology; 2004 Jan; 29(1):93-100. PubMed ID: 14571256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granisetron and ondansetron: effects on the ileal brake mechanism in the rat.
    Brown NJ; Horton A; Rumsey RD; Read NW
    J Pharm Pharmacol; 1993 Jun; 45(6):521-4. PubMed ID: 8103099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a 5-HT3-antagonist on the ileal brake mechanism in the rat.
    Brown NJ; French SJ; Rumsey RD; Read NW
    J Pharm Pharmacol; 1991 Jul; 43(7):517-9. PubMed ID: 1682469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of the 5-HT3 receptor antagonist BRL 43694; effects on reflex epilepsy and social behaviour of the Mongolian gerbil.
    Cutler MG; Piper DC
    Psychopharmacology (Berl); 1990; 101(2):244-9. PubMed ID: 2161551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of galanin on passive avoidance response, elevated plus-maze learning, and spontaneous alternation performance in mice.
    Ukai M; Miura M; Kameyama T
    Peptides; 1995; 16(7):1283-6. PubMed ID: 8545252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different temporal effects of serotonergic antagonists on passive avoidance retention.
    Altman HJ; Normile HJ
    Pharmacol Biochem Behav; 1987 Nov; 28(3):353-9. PubMed ID: 3685070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Nitroindazole, a neuronal nitric oxide synthase inhibitor, impairs passive-avoidance and elevated plus-maze memory performance in rats.
    Yildiz Akar F; Ulak G; Tanyeri P; Erden F; Utkan T; Gacar N
    Pharmacol Biochem Behav; 2007 Oct; 87(4):434-43. PubMed ID: 17602730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intra-amygdala injections of NMDA receptor antagonists on acquisition and retention of inhibitory avoidance.
    Kim M; McGaugh JL
    Brain Res; 1992 Jul; 585(1-2):35-48. PubMed ID: 1387340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blind mice are not impaired in T-maze footshock avoidance acquisition and retention.
    Farr SA; Banks WA; La Scola ME; Morley JE
    Physiol Behav; 2002 Aug; 76(4-5):531-8. PubMed ID: 12126989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of agonists and antagonists of some serotonin-receptor subtypes on memory and their modulation by the 5-HT-uptake inhibitor fluoxetine.
    Petkov VD; Kehayov R
    Acta Physiol Pharmacol Bulg; 1994; 20(3-4):83-90. PubMed ID: 7645408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694).
    Reynolds DJ; Barber NA; Grahame-Smith DG; Leslie RA
    Brain Res; 1991 Nov; 565(2):231-6. PubMed ID: 1668810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of memory retrieval and attenuation of scopolamine-induced amnesia following administration of 5-HT3 antagonist ICS 205-930.
    Chugh Y; Saha N; Sankaranarayanan A; Datta H
    Pharmacol Toxicol; 1991 Aug; 69(2):105-6. PubMed ID: 1775428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.